Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Common Equity (2018 - 2025)

AdaptHealth has reported Common Equity over the past 8 years, most recently at $1.5 billion for Q4 2025.

  • Quarterly results put Common Equity at $1.5 billion for Q4 2025, down 3.77% from a year ago — trailing twelve months through Dec 2025 was $1.5 billion (down 3.77% YoY), and the annual figure for FY2025 was $1.5 billion, down 3.77%.
  • Common Equity for Q4 2025 was $1.5 billion at AdaptHealth, down from $1.6 billion in the prior quarter.
  • Over the last five years, Common Equity for AHCO hit a ceiling of $2.2 billion in Q2 2023 and a floor of $1.5 billion in Q4 2023.
  • Median Common Equity over the past 5 years was $1.8 billion (2021), compared with a mean of $1.8 billion.
  • Biggest five-year swings in Common Equity: skyrocketed 1970.36% in 2021 and later tumbled 32.13% in 2024.
  • AdaptHealth's Common Equity stood at $2.1 billion in 2021, then rose by 4.41% to $2.2 billion in 2022, then plummeted by 32.03% to $1.5 billion in 2023, then grew by 7.6% to $1.6 billion in 2024, then dropped by 3.77% to $1.5 billion in 2025.
  • The last three reported values for Common Equity were $1.5 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.6 billion (Q2 2025) per Business Quant data.